Elanco beats Q2 expectations and raises 2025 guidance as strong Pet Health sales and FX tailwinds offset tariff and investment impacts.
Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook
Where Today's News Shapes Tomorrow
